Back to JANE STREET GROUP, LLC JANE STREET GROUP, LLC

CAPRCAPR

Showing 7 of 16 quarters

Position history for JANE STREET GROUP, LLCJANE STREET GROUP, LLC's holdings in CAPRICOR THERAPEUTICS INC

No. Jane Street Group exited its CAPR (Capricor Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 566,081 shares worth $17.2M. Jane Street Group first reported CAPR in Q1 2020 and held it in 11 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$1.5M

Total Shares Change

-99,126

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$24.08
0
2026-Q1
New
566,081
—
$17.2M0.0%$30.40
39
2025-Q4
Exited
0
-100.0%
$00.0%$28.86
0
2025-Q3
New
68,145
—
$491,3250.0%$7.21
33
2025-Q1
Exited
0
-100.0%
$00.0%$9.49
0
2024-Q4
Increased
103,734
+4.7%
$1.4M0.0%$13.80
27
2024-Q3
Increased
99,126
+441.2%
$1.5M0.0%$15.21
41

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used